Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists, endocrinologists and other physicians.
| NASDAQ: SNTS |
| Current Price: 2.24 |
| Change: -0.01 |
9/3/2010 3:44:07 PM EST
Quotes delayed 20 minutes.
|
|
8/30/2010
Santarus Extends Maturity of $25 Million Revolving Line of Credit to July 2013
8/2/2010
Santarus Reports Second Quarter 2010 Financial Results
7/28/2010
Santarus to Present at BMO Capital Markets 10th Annual Focus on Healthcare Conference
|
Santarus is hiring skilled people like you. Join our team today!
